Assessing Intensive Care Unit (ICU) Indications: Human vs. ChatGPT-4o Predictions

NCT ID: NCT06726733

Last Updated: 2024-12-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-12-28

Study Completion Date

2025-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This retrospective study evaluates the accuracy of ICU admission indications by comparing clinical decisions with predictions from ChatGPT-4. Patient data, including demographics, vital signs, laboratory results, imaging findings, and clinical decisions, will be retrospectively collected and documented systematically using Case Report Forms. The model will be trained using ICU admission guidelines and tasked to predict ICU needs based on collected patient data. This study aims to systematically assess the alignment between AI-based predictions and clinical decisions for ICU admissions.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study has a retrospective design. The medical data of patients admitted to the emergency department and consulted to the anesthesiology and reanimation clinic for ICU indications will be collected retrospectively. Demographic information, vital signs, laboratory results, imaging findings, and clinical decisions of the patients will be recorded. These data will be systematically collected for each patient using an individual Case Report Form.

Inclusion Criteria for the Study:

Patients aged 18 years and older who were consulted to the anesthesiology and reanimation clinic for ICU indications from the emergency department will be included in the study.

Exclusion Criteria for the Study:

Patients consulted to the anesthesiology and reanimation clinic for ICU indications from inpatient services.

Patients consulted to the anesthesiology and reanimation clinic from the emergency department for reasons other than ICU indications.

Patients consulted to the anesthesiology and reanimation clinic for ICU indications from the emergency department but with insufficient recorded data (patients with data loss).

Model Training and Prediction Analysis:

ChatGPT-4 will be trained according to the guidelines in "Yoğun Bakım Hasta Kabul Kriterleri (Rehberleri)" by Çiftçi B, Erdoğan C, and Demiraran Y (5). The collected patient data will be presented to the ChatGPT-4 model to obtain predictions regarding whether the patients require ICU admission. The predictions made by ChatGPT will be compared with clinical decisions, and accuracy rate, false positive rate, and false negative rate will be analyzed.

Statistical Analysis Methods to Be Used in the Study:

Accuracy Rate: The rate at which ChatGPT correctly predicts ICU indications will be calculated.

False Positive Rate: The rate at which ChatGPT predicts ICU need for patients who do not require ICU admission will be evaluated.

False Negative Rate: The rate at which ChatGPT predicts no ICU need for patients who require ICU admission will be analyzed.

Kappa Statistics: The agreement between ChatGPT predictions and clinical decisions will be measured.

ROC Curve and AUC: The performance of ChatGPT will be evaluated using the ROC curve and AUC.

The Case Report Form used for each patient ensures detailed and systematic data collection of clinical information, aiming to meaningfully compare the alignment of ChatGPT's predictions with clinical decisions.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Intensive Care Unit (ICU) Admission Emergency Department Patient Artificial Intelligence (AI) Clinical Decision-making

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

AI Intensive Care Unit Clinical decision-making Artificial Intelligenc

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients aged 18 years and older who are consulted to the anesthesiology and reanimation clinic for ICU indications from the emergency department will be included in the study.

Exclusion Criteria

* Patients consulted to the anesthesiology and reanimation clinic for ICU indications from inpatient services.
* Patients consulted to the anesthesiology and reanimation clinic from the emergency department for reasons other than ICU indications.
* Patients consulted to the anesthesiology and reanimation clinic for ICU indications from the emergency department but with insufficient recorded data (patients with data loss)
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Bursa Yuksek Ihtisas Training and Research Hospital

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Aycan KURTARANGİL DOĞAN

Doctor of anesthesiology and reanimation

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

İlkay Ceylan

Role: PRINCIPAL_INVESTIGATOR

[email protected]

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Bursa Yuksek Ihtisas Training and Research Hospital

Bursa, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

İlkay Ceylan

Role: CONTACT

Phone: +902243664434

Email: [email protected]

Aycan Kurtarangil Doğan

Role: CONTACT

Phone: +902243664434

Email: [email protected]

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

BYIEAH-INKA

Identifier Type: -

Identifier Source: org_study_id